VRNA vs. SPMO

Last updated Jun 25, 2026

VRNA (Verona Pharma plc) is a stock, while SPMO (Invesco S&P 500 Momentum ETF) is Momentum fund tracking the S&P 500 Momentum Index. At a 0.18 correlation, their price movements are largely independent.

Performance

VRNA vs. SPMO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Verona Pharma plc (VRNA) and Invesco S&P 500 Momentum ETF (SPMO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

VRNA

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

SPMO

• 1D: -0.36%
• 1M: 6.27%
• YTD: 29.45%
• 6M: 27.18%
• 1Y: 41.07%
• 3Y*: 42.30%
• 5Y*: 22.83%
• 10Y*: 20.99%

*Multi-year figures are annualized to reflect compound growth (CAGR)

VRNA vs. SPMO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
VRNA Verona Pharma plc	0.00%	130.21%	133.60%	-23.92%	288.84%	-4.00%	21.74%	-40.41%	-18.71%	-12.07%
SPMO Invesco S&P 500 Momentum ETF	29.45%	26.58%	45.82%	17.56%	-10.45%	22.64%	28.25%	25.93%	-0.92%	20.93%

Correlation

The correlation between VRNA and SPMO is -0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.02
Correlation (3Y) Calculated over the trailing 3-year period	0.25
Correlation (5Y) Calculated over the trailing 5-year period	0.23
Correlation (All Time) Calculated using the full available price history since Apr 27, 2017	0.18

The correlation between VRNA and SPMO shifts across timeframes, from -0.02 (1 year) to 0.25 (3 years), reflecting how their relationship changes across market environments.

Return for Risk

VRNA vs. SPMO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VRNA

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

SPMO

SPMO Risk / Return Rank: 70
SPMO Sharpe Ratio Rank: 70
SPMO Sortino Ratio Rank: 65
SPMO Omega Ratio Rank: 70
SPMO Calmar Ratio Rank: 71
SPMO Martin Ratio Rank: 73

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VRNA vs. SPMO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Verona Pharma plc (VRNA) and Invesco S&P 500 Momentum ETF (SPMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	VRNA	SPMO	Difference
Sharpe ratio: Return per unit of total volatility	—	2.02	—
Sortino ratio: Return per unit of downside risk	—	2.68	—
Omega ratio: Gain probability vs. loss probability	—	1.37	—
Calmar ratio: Return relative to maximum drawdown	—	3.25	—
Martin ratio: Return relative to average drawdown	—	12.18	—

Drawdowns

Drawdown Indicators

	VRNA	SPMO	Difference
Max Drawdown Largest peak-to-trough decline	—	-30.95%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-12.70%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-20.13%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-22.74%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-30.95%	—
Current Drawdown Current decline from peak	—	-4.87%	—
Average Drawdown Average peak-to-trough decline	—	-4.59%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	3.38%	—

Volatility

Volatility by Period

	VRNA	SPMO	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	11.77%	—
Volatility (6M) Calculated over the trailing 6-month period	—	17.74%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	20.51%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	19.87%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	20.60%	—

Dividends

VRNA vs. SPMO - Dividend Comparison

VRNA has not paid dividends to shareholders, while SPMO's dividend yield for the trailing twelve months is around 0.68%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
SPMO Invesco S&P 500 Momentum ETF	0.68%	0.73%	0.48%	1.63%	1.66%	0.52%	1.27%	1.39%	1.05%	0.77%	1.94%	0.36%
VRNA Verona Pharma plc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both VRNA and SPMO in my portfolio?

VRNA and SPMO have a correlation of -0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.